A Systematic Review and Meta-Analysis of the Efficacy of Piracetam and Piracetam-Like Compounds in Experimental Stroke

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cerebrovascular Diseases

• Publication date

  2007-11-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000111493PMID 18033952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic Review and Meta-Analysis of the Efficacy of Tirilazad in Experimental Stroke

  2007cited by this paper
• Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis.

  2007cited by this paper
• Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib

  2006cited by this paper
• 1,026 Experimental treatments in acute stroke

  2006cited by this paper
• Comparison of treatment effects between animal experiments and clinical trials: systematic review

  2006cited by this paper
• Systematic Review and Metaanalysis of the Efficacy of FK506 in Experimental Stroke

  2005cited by this paper
• Antimyoclonic Efficacy of Piracetam in Idiopathic Generalized Epilepsy

  2005cited by this paper
• Pooling of Animal Experimental Data Reveals Influence of Study Design and Publication Bias

  2004cited by this paper
• Recommendations for Advancing Development of Acute Stroke Therapies: Stroke Therapy Academic Industry Roundtable 3

  2003cited by this paper
• Neuroprotective effects on somatotopic maps resulting from piracetam treatment and environmental enrichment after focal cortical injury.

  2003cited by this paper
• Piracetam for acute ischaemic stroke.

  2002cited by this paper
• Clomethiazole Acute Stroke Study in Ischemic Stroke (CLASS-I): Final Results

  2002cited by this paper
• The 2-oxopyrrolidinacetamide piracetam reduces infarct brain volume induced by permanent middle cerebral artery occlusion in male rats.

  2002cited by this paper
• Long-term efficacy and safety of piracetam in the treatment of progressive myoclonus epilepsy.

  2001cited by this paper
• Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia.

  2001cited by this paper
• The Failure of Neuronal Protective Agents Versus the Success of Thrombolysis in the Treatment of Ischemic Stroke

  2001cited by this paper
• Nimodipine in Animal Model Experiments of Focal Cerebral Ischemia: A Systematic Review

  2001cited by this paper
• Tirilazad mesylate in acute ischemic stroke - A systematic review

  2000cited by this paper
• Piracetam Improves Activated Blood Flow and Facilitates Rehabilitation of Poststroke Aphasic Patients

  2000cited by this paper
• Tirilazad Mesylate in Acute Ischemic Stroke: A Systematic Review

  2000cited by this paper
• Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups.

  2000cited by this paper
• Memory restoring and neuroprotective effects of the proline-containing dipeptide, GVS-111, in a photochemical stroke model.

  1999cited by this paper
• Substituted Acyl-proline Glycine Gvs-111 Combines Cognition Enhancing And Neuroprotective Activities

  1999cited by this paper
• Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo

  1998cited by this paper
• Treatment of acute ischemic stroke with piracetam. Members of the Piracetam in Acute Stroke Study (PASS) Group.

  1997cited by this paper
• Treatment of Acute Ischemic Stroke With Piracetam

  1997cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Piracetam and other structurally related nootropics.

  1994cited by this paper
• Effect of oxiracetam on cerebrovascular impairment in rats.

  1991cited by this paper
• Double-blind placebo-controlled, neuropsychological and neurophysiological investigations with oxiracetam (CGP 21690E) in memory-impaired patients with epilepsy.

  1990cited by this paper
• [Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology].

  1972cited by this paper

• Predictors of All-cause Mortality among Stroke Patients in Kazakhstan: A Retrospective Study Using Integrated AI Data Extraction

  2025cites this paper
• The hazards of chasing subgroups in neutral stroke trials

  2025cites this paper
• In Vivo Neuroprotective Effects of Alpinetin Against Experimental Ischemic Stroke Damage Through Antioxidant and Anti-Inflammatory Mechanisms

  2025cites this paper
• Neuroprotective agents in acute ischemic stroke

  2023cites this paper
• Case Report: Ischaemic Stroke Presented with Hemichorea-Hemiballism

  2023cites this paper
• Comparison of the Effects of Citicoline and Piracetam on Hypoxic-ischemic Brain Damage in Neonatal Rabbits

  2022cites this paper
• Does resveratrol enhance recovery from acute ischemic stroke? A randomized, double-blinded, placebo-controlled trial

  2022cites this paper
• Pharmacological characterization of a novel putative nootropic beta-alanine derivative, MB-005, in adult zebrafish

  2022cites this paper
• A Review on Synthesis and Pharmacological Activities of Piracetam and its Derivatives

  2021cites this paper
• Effect of uric acid in animal models of ischemic stroke: A systematic review and meta-analysis

  2020cites this paper
• Pharmacological Interventions to Enhance Stroke Recovery

  2019cites this paper
• The Conditions Under Which Piracetam Is Used and the Factors That Can Improve National Institute of Health Stroke Scale Score in Ischemic Stroke Patients and the Importance of Previously Unnoticed Factors From a Hospital-Based Observational Study in Taiwan

  2019cites this paper
• Estimating the statistical performance of different approaches to meta-analysis of data from animal studies in identifying the impact of aspects of study design

  2018cites this paper
• Systematic Review and Meta-analysis: Important Tools in Understanding Drug Development for Stroke

  2017cites this paper
• Hyperbaric oxygen for experimental intracerebral haemorrhage: Systematic review and stratified meta-analysis

  2017cites this paper
• Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials

  2016cites this paper
• Asymmetric synthesis of 3-prenyl-substituted pyrrolidin-2-ones

  2016cites this paper
• Clinical Translation in Central Nervous System Diseases: Ethical and Social Challenges

  2015cites this paper
• The use of systematic reviews and reporting guidelines to advance the implementation of the 3Rs.

  2015cites this paper
• Timing and number of minor infections as risk factors for childhood arterial ischemic stroke

  2014cites this paper
• Critical appraisal of studies using laboratory animal models.

  2014cites this paper
• The Need for Randomization in Animal Trials: An Overview of Systematic Reviews

  2014cites this paper
• Meta-analysis of the Efficacy of Different Training Strategies in Animal Models of Ischemic Stroke

  2014cites this paper
• Late, never or non‐existent: the inaccessibility of preclinical evidence for new drugs

  2014cites this paper
• Pathophysiology of post-stroke hyperglycaemia and brain arterial patency

  2013cites this paper
• Exploring the Efficacy of Constraint in Animal Models of Stroke

  2013cites this paper
• STUDI PENGGUNAAN OBAT NEUROPROTEKTAN PADA PASIEN STROKE ISKEMIK (Penelitian Di Rumah Sakit Umum Dr. Saiful Anwar Malang)

  2013cites this paper
• A utilização em terapêutica de substâncias com atividade nootrópica

  2013cites this paper
• A call for transparent reporting to optimize the predictive value of preclinical research

  2012cites this paper
• Hyperglycaemia and Infarct Size in Animal Models of Middle Cerebral Artery Occlusion: Systematic Review and Meta-Analysis

  2011cites this paper
• Does long term use of piracetam improve speech disturbances due to ischemic cerebrovascular diseases?

  2011cites this paper
• An Enriched Environment Improves Sensorimotor Function Post-Ischemic Stroke

  2010cites this paper
• Piracetam and Piracetam-Like Drugs

  2010cites this paper
• Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy

  2010cites this paper
• Intravenous Route of Cell Delivery for Treatment of Neurological Disorders: A Meta-Analysis of Preclinical Results

  2010cites this paper
• What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma

  2008cites this paper
• Empirical Evidence of Bias in the Design of Experimental Stroke Studies: A Metaepidemiologic Approach

  2008cites this paper
• A Call for Transparent Reporting to Optimize the Predictive Value of Preclinical Research Repository Citation

  year unknowncites this paper
• Piracetam and Piracetam-Like Drugs From Basic Science to Novel Clinical Applications to CNS Disorders

  year unknowncites this paper